The Discounted Cash Flow (DCF) valuation of ADMA Biologics Inc (ADMA) is 18.54 USD. With the latest stock price at 18.51 USD, the upside of ADMA Biologics Inc based on DCF is 0.2%.
Based on the latest price of 18.51 USD and our DCF valuation, ADMA Biologics Inc (ADMA) is a buy. buying ADMA stocks now will result in a potential gain of 0.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.8% | 8.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 11.77 - 44.39 | 18.54 |
| Upside | -36.4% - 139.8% | 0.2% |